June 27, 2024

U.S. Sen. Marsha Blackburn (R-TN) led a bipartisan group of senators in a communication to the Centers for Medicare and Medicaid Services (CMS) requesting the agency improve patients’ access to positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans by addressing inadequate packaging of payment for diagnostic radiopharmaceuticals used in diagnostic scans.

These scans help physicians identify certain diseases more effectively, including Alzheimer’s, Parkinson’s, advanced cardiovascular disease and prostate cancer.

The American College of Radiology® (ACR®) long supported addressing the packaging of payment for diagnostic radiopharmaceuticals so that beneficiaries have access to the care they need. The College continues to advocate with other organizations to ensure CMS includes something on this issue in upcoming rulemaking.

For questions, contact Ashley Walton, ACR Government Affairs Director.


Related ACR News

  • ACR Advises Changes to Washington State PAD Report

    ACR urged the WA State Health Technology Clinical Committee to not act on the draft report that would limit coverage of endovascular procedures for PAD.

    Read more
  • ACR Releases Impact Tables for 2026 MPFS Proposed Rule

    The tables cover specific proposed changes in reimbursement rates between 2025 and 2026 for each CPT® code.

    Read more
  • Take Action: Contact Your US Senators to Cosponsor ROOT Act

    Support the ROOT Act—Senate cosponsors needed to fix CMS issues with imaging AUC under PAMA. College member advocacy is key.

    Read more